MedTrace Logo

Effects of Pregabalin, Duloxetine & Amitriptyline on Pain & Sleep

NCT00370656 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2009-11-17

No results posted yet for this study

Summary

The purpose of this study is to assess the effectiveness of pregabalin, duloxetine and amitriptyline compared with placebo in reducing pain in diabetic patients as assessed by Brief Pain Inventory (BPI).

Conditions

Interventions

DRUG

Pregabalin

capsule, 150mg bd, 300mg bd

DRUG

Duloxetine

Capsule, 60mg on, 60mg bd

DRUG

Amitriptyline

Capsule. 25 mg bd, 25 mg om and 50 mg on

Sponsors & Collaborators

  • University of Surrey

    lead OTHER

Principal Investigators

  • Professor AN Nicholson · University of Surrey

  • Dr D Kerr · Royal Bournemouth Hospital

  • Dr D Coppini · Poole General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2009-05-31
Completion
2009-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00370656 on ClinicalTrials.gov